Semisolid Dosage
Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of “ointments” as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemi...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (182 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545927104498 |
---|---|
ctrlnum |
(CKB)5400000000043359 (oapen)https://directory.doabooks.org/handle/20.500.12854/68985 (EXLCZ)995400000000043359 |
collection |
bib_alma |
record_format |
marc |
spelling |
Daniels, Rolf edt Semisolid Dosage Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (182 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of “ointments” as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemical characterization of ointments as well as the inclusion of dermatological aspects led to a comprehensive understanding of the various interactions between the vehicle, the active ingredient and the skin. From then on, many researchers were involved in optimizing semi-solid formulations with respect to continuously changing therapeutic and patient needs. Aspects that have been dealt with were the optimization of dermato-biopharmaceutical properties and many different issues related to patient compliance, such as skin tolerance, applicability, and cosmetic appeal. Moreover, processing technology has been improved and analytical techniques were developed and refined in order to enable the improved characterization of the formulation itself as well as its interaction with the skin. This Special Issue serves to highlight and capture the contemporary progress and current research on semi-solid formulations as dermal drug delivery systems. We invite articles on all aspects of semi-solid formulations, highlighting the research currently undertaken to improve and better understand these complex drug delivery systems with respect to their formulation, processing and characterization issues. English Medicine bicssc dermal drug delivery diffusion cell Franz diffusion Skin-PAMPA Strat-M® membrane nanocarrier nonivamide methyl cellulose skin penetration substantivity thermogel tacrolimus formulation nanogels drug delivery human excised skin Jurkat cells in situ hydrogel-forming powder nitric oxide-releasing formulation S-nitrosoglutathione (GSNO) antibacterial wound dressing wound healing dermal delivery porcine skin in vitro permeation methadone pain in vitro permeation niacinamide solvent PAMPA skin curcumin deformable liposomes liposome surface charge hydrogel chitosan wound therapy IVRT metronidazole topical cream semisolid dosage forms sameness FDA's SUPAC-SS guidance acceptance criteria positive and negative controls discriminatory ability Amphotericin B Sepigel 305® Leishmania infantum cutaneous leishmaniasis topical treatment birch bark extract oleogels hydrogen bonding triterpene rheology gel strength eosinophilic esophagitis budesonide xanthan gum guar gum mucoadhesion esophagus permeability rheological characterization pediatric medicine compounded preparation non-ionic emulsifiers intercellular lipids confocal Raman spectroscopy (CRS) polyethylene glycol alkyl ethers polyethylene glycol sorbitan fatty acid esters 3-03936-948-2 3-03936-949-0 Lunter, Dominique edt Daniels, Rolf oth Lunter, Dominique oth |
language |
English |
format |
eBook |
author2 |
Lunter, Dominique Daniels, Rolf Lunter, Dominique |
author_facet |
Lunter, Dominique Daniels, Rolf Lunter, Dominique |
author2_variant |
r d rd d l dl |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Semisolid Dosage |
spellingShingle |
Semisolid Dosage |
title_full |
Semisolid Dosage |
title_fullStr |
Semisolid Dosage |
title_full_unstemmed |
Semisolid Dosage |
title_auth |
Semisolid Dosage |
title_new |
Semisolid Dosage |
title_sort |
semisolid dosage |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (182 p.) |
isbn |
3-03936-948-2 3-03936-949-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT danielsrolf semisoliddosage AT lunterdominique semisoliddosage |
status_str |
n |
ids_txt_mv |
(CKB)5400000000043359 (oapen)https://directory.doabooks.org/handle/20.500.12854/68985 (EXLCZ)995400000000043359 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Semisolid Dosage |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1787548474245382144 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04855nam-a2201189z--4500</leader><controlfield tag="001">993545927104498</controlfield><controlfield tag="005">20231214132847.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043359</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68985</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043359</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Daniels, Rolf</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Semisolid Dosage</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (182 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of “ointments” as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemical characterization of ointments as well as the inclusion of dermatological aspects led to a comprehensive understanding of the various interactions between the vehicle, the active ingredient and the skin. From then on, many researchers were involved in optimizing semi-solid formulations with respect to continuously changing therapeutic and patient needs. Aspects that have been dealt with were the optimization of dermato-biopharmaceutical properties and many different issues related to patient compliance, such as skin tolerance, applicability, and cosmetic appeal. Moreover, processing technology has been improved and analytical techniques were developed and refined in order to enable the improved characterization of the formulation itself as well as its interaction with the skin. This Special Issue serves to highlight and capture the contemporary progress and current research on semi-solid formulations as dermal drug delivery systems. We invite articles on all aspects of semi-solid formulations, highlighting the research currently undertaken to improve and better understand these complex drug delivery systems with respect to their formulation, processing and characterization issues.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dermal drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diffusion cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Franz diffusion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Skin-PAMPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Strat-M® membrane</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanocarrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nonivamide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methyl cellulose</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin penetration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">substantivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thermogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tacrolimus formulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanogels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human excised skin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Jurkat cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in situ hydrogel-forming powder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nitric oxide-releasing formulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">S-nitrosoglutathione (GSNO)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound dressing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound healing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dermal delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">porcine skin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro permeation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methadone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">permeation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">niacinamide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solvent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PAMPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">curcumin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">deformable liposomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liposome surface charge</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chitosan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IVRT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metronidazole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">topical cream</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">semisolid dosage forms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sameness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FDA's SUPAC-SS guidance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acceptance criteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positive and negative controls</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">discriminatory ability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Amphotericin B</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sepigel 305®</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Leishmania infantum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cutaneous leishmaniasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">topical treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">birch bark extract</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oleogels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen bonding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triterpene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gel strength</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">eosinophilic esophagitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">budesonide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">xanthan gum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guar gum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucoadhesion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">esophagus permeability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheological characterization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pediatric medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">compounded preparation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-ionic emulsifiers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intercellular lipids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">confocal Raman spectroscopy (CRS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyethylene glycol alkyl ethers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyethylene glycol sorbitan fatty acid esters</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-948-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03936-949-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lunter, Dominique</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Daniels, Rolf</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lunter, Dominique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:34:26 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338090690004498&Force_direct=true</subfield><subfield code="Z">5338090690004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338090690004498</subfield></datafield></record></collection> |